Key regions: France, Australia, India, South Korea, Germany
The Other OTC Pharmaceuticals (Pharmacies) market in Algeria is experiencing steady growth due to several factors. Customer preferences for over-the-counter medications, the increasing availability of these products in pharmacies, and local special circumstances are all contributing to the development of the market. Customer preferences in Algeria are shifting towards self-medication and the use of over-the-counter pharmaceuticals. This is driven by a desire for convenience and cost-effectiveness. Consumers are increasingly looking for quick and accessible solutions to common health issues, and over-the-counter medications provide a convenient option. Additionally, the growing awareness and knowledge about these products among consumers is also contributing to their popularity. The availability of over-the-counter pharmaceuticals in pharmacies is expanding in Algeria. Pharmacies are becoming a one-stop-shop for consumers, offering a wide range of over-the-counter medications alongside prescription drugs. This trend is driven by the increasing demand for these products and the recognition of pharmacies as trusted sources of healthcare advice. Pharmacies are also investing in marketing and promotional activities to attract customers to their over-the-counter pharmaceutical offerings. Local special circumstances in Algeria are also playing a role in the development of the Other OTC Pharmaceuticals (Pharmacies) market. The country has a high prevalence of certain health conditions, such as respiratory diseases and digestive disorders, which can be managed with over-the-counter medications. This creates a significant market opportunity for over-the-counter pharmaceuticals in Algeria. Additionally, the government has been taking steps to promote the use of over-the-counter medications as a means to reduce the burden on the healthcare system and improve access to healthcare for the population. Underlying macroeconomic factors are also contributing to the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Algeria. The country's economy has been growing steadily, leading to an increase in disposable income and consumer spending. This has resulted in higher demand for healthcare products, including over-the-counter pharmaceuticals. Additionally, the government has been investing in the healthcare sector, which has improved the overall infrastructure and accessibility of healthcare services, including pharmacies. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Algeria is developing due to customer preferences for over-the-counter medications, the increasing availability of these products in pharmacies, local special circumstances, and underlying macroeconomic factors. As customer awareness and demand continue to grow, the market is expected to expand further in the coming years.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
